Science University Research Symposium (SURS)

Evaluating EGR1 Feedback on Wnt/β-Catenin Signaling and Dependence on p53 in HCT116 Colorectal Cancer Cells

Publication Date

Fall 11-23-2026

College

College of Sciences & Mathematics

Department

Biology, Department of

SURS Faculty Advisor

Dr. Erick Spears

Presentation Type

Poster Presentation

Abstract

Cells are regulated through the expression of genes that control processes like proliferation and cell death. Proliferation in human intestinal epithelium is regulated by the Wnt/β-catenin pathway, which stimulates the expression of MYC, resulting in proliferation. When Wnt binds to its receptor, cytoplasmic β-catenin is stabilized, is translocated into the nucleus, and upregulates genes that drive proliferation. One of the major cell cycle regulatory genes targeted by this activity is MYC. In colorectal cancer, the Wnt/β-catenin pathway is deregulated, thus deregulating MYC expression and driving the uncontrolled proliferation that defines the cancer phenotype. The progression of colorectal cancer very often results in mutation of the TP53 (the gene coding the p53 tumor suppressor protein) and loss of its tumor suppressive function. Interestingly, under cellular conditions where p53 function is lost, MYC has been shown to switch to a proapoptotic protein by stimulating the expression of EGR1 (here termed the MYC-EGR1 pathway). These experiments seek to identify any feedback control of the Wnt/β-catenin pathway by EGR1, which might have further impact on growth of colorectal cancer cells. HCT116 colorectal cancer cells with and without functional p53 were stably transduced with shRNA targeting EGR1 expression or with a non-targeting (scrambled) control shRNA, and expression of standard Wnt/β-catenin pathway target genes, AXIN2 and SOX17, was assessed by quantitative real time reverse transcriptase PCR analysis. To assess whether this feedback on the Wnt/β-catenin pathway is specific to the MYC-EGR1 pathway or MYC-independent, p53-variant HCT116 cell lines were also transduced with shRNA targeting MYC expression. Understanding the role of EGR1 feedback on Wnt/β-catenin signaling could lead to a better understanding of the potential for targeting the MYC-EGR1 pathway to treat colorectal cancer.

This document is currently not available here.

Share

COinS